市場調查報告書

血液腫瘤檢驗的全球市場:各產品,各癌症類型,各技術,各最終用途,各地區的市場規模,佔有率及趨勢分析,各市場區隔預測(2020年∼2027年)

Hemato Oncology Testing Market Size, Share & Trends Analysis Report By Product (Assay Kits & Reagents, Services), By Cancer Type (Leukemia, Lymphoma, MPNs), By Technology, By End-use, By Region, And Segment Forecasts, 2020 - 2027

出版商 Grand View Research, Inc. 商品編碼 968628
出版日期 內容資訊 英文 142 Pages
商品交期: 2-3個工作天內
價格
血液腫瘤檢驗的全球市場:各產品,各癌症類型,各技術,各最終用途,各地區的市場規模,佔有率及趨勢分析,各市場區隔預測(2020年∼2027年) Hemato Oncology Testing Market Size, Share & Trends Analysis Report By Product (Assay Kits & Reagents, Services), By Cancer Type (Leukemia, Lymphoma, MPNs), By Technology, By End-use, By Region, And Segment Forecasts, 2020 - 2027
出版日期: 2020年10月16日內容資訊: 英文 142 Pages
簡介

全球血液腫瘤檢驗的市場規模在2020年∼2027年間,預測將以14.6%的年複合成長率擴大,到2027年達到72億美元。白血病,淋巴瘤,骨髓增生性新生物,及多發性骨髓瘤發生率的上升推動了市場的增長。此外,各種大型公司與研究機構之間的合作日益增強,學術研究機構為發展技術先進的血液系統惡性腫瘤而開展的研究活動也有望推動市場增長。

本報告提供全球血液腫瘤檢驗市場相關調查分析,提供市場及產業預測,各市場區隔·各地區的預測,加上競爭情形相關的系統性資訊。

目錄

第1章 調查方法與範圍

第2章 摘要整理

第3章 血液腫瘤檢驗市場變數,趨勢及範圍

  • 市場系統預測
  • 滲透與成長預測的製圖
  • 法律規範
  • 市場動態
  • 血液腫瘤檢驗市場分析工具

第4章 血液腫瘤檢驗市場-競爭分析

  • 主要市場參與者的最新趨勢和影響分析
  • 企業的分類
    • 主要的分銷商和流通管道合作夥伴清單
  • 公開企業
    • 企業的市場情況分析
  • 非公開企業
    • 主要的新興企業清單
    • 地區網路地圖
    • 企業的市場情況分析

第5章 各癌症類型市場估計·趨勢分析

  • 定義和範圍
  • 各癌症類型市場佔有率分析,2019年及2027年
  • 市場區隔儀表板
  • 全球血液腫瘤檢驗市場,各癌症類型,2016年∼2027年
  • 市場規模與預測及趨勢分析,2016年∼2027年
  • 白血病
  • 淋巴瘤
  • 骨髓增生性腫瘤
  • 其他癌症

第6章 血液腫瘤檢驗市場:各產品市場估計·趨勢分析

  • 定義和範圍
  • 各產品市場佔有率分析,2019年及2027年
  • 市場區隔儀表板
  • 全球血液腫瘤檢驗市場,各產品,2016年∼2027年
  • 市場規模與預測及趨勢分析,2016年∼2027年
  • 化驗套件及試劑
  • 服務

第7章 血液腫瘤學檢驗市場:各技術市場估計·趨勢分析

  • 定義和範圍
  • 各技術市場佔有率分析,2019年及2027年
  • 市場區隔儀表板
  • 全球血液腫瘤檢驗市場,各技術,2016年∼2027年
  • 市場規模與預測及趨勢分析,2016年∼2027年
  • PCR
  • IHC
  • NGS
  • 細胞遺傳學
  • 其他科技

第8章 血液腫瘤檢驗市場:各最終用途市場估計·趨勢分析

  • 定義和範圍
  • 最終用途的市場佔有率分析,2019年及2027年
  • 市場區隔儀表板
  • 全球血液腫瘤檢驗市場,各最終用途,2016年∼2027年
  • 市場規模與預測及趨勢分析,2016年∼2027年
  • 醫院
  • 學術·研究機關
  • 其他

第9章 血液腫瘤檢驗市場:各地區市場的估計·趨勢分析

  • 各地區市場的概述
  • 各國市場佔有率分析,2019年
    • 北美
    • 歐洲
    • 南美
    • 亞太地區
    • 中東·非洲
  • 要因別的SWOT分析(政治及法律,經濟及技術性)
    • 北美
    • 歐洲
    • 南美
    • 亞太地區
    • 中東·非洲
  • 市場規模與預測,及趨勢分析,2016年∼2027年
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東·非洲

第10章 企業簡介

  • 企業簡介
目錄
Product Code: GVR-4-68039-174-2

Hemato Oncology Testing Market Growth & Trends

The global hemato oncology testing market size is expected to reach USD 7.2 billion by 2027, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 14.6% from 2020 to 2027. Key drivers for the market include rising incidences of leukemia, lymphoma, myeloproliferative neoplasms, and multiple myeloma. Also, growing collaborations among various major players and research organizations, and an increasing number of research activities conducted by academic and research institutes to develop technologically advanced hemato oncology tests is anticipated to fuel market growth.

The rising prevalence of lymphoma and myeloma is anticipated to propel the market growth during the forecast period. According to a report published by the American Cancer Society, it is estimated that there over 32,270 new cases of multiple myeloma which included 14,740 women and 17,530 men in 2018. Whereas, over 12,830 deaths were recorded in 2018 that included 5,640 women and 7,190 men. Therefore, a rise in the prevalence of the above-mentioned diseases is expected to enhance the usage of hemato oncology testing products.

An increase in the number of product launches is also a major factor contributing to the growth of the market. For instance, in October 2018, MedGenome launched the IGHV gene mutation testing. This test enables health care professionals to access the prognosis of chronic lymphocytic leukemia, and further manage the disease by personalized therapy.

The FDA approval of Invivoscribe's LeukoStrat companion diagnostic test in conjugation with Novartis's Rydapt for detection and treatment of AML has been a key factor in the rising number of manufacturers opting for the development of related products. The CE approved assay was launched in 2017, being the first companion diagnostic to be used for the detection of AML. Similarly, in the year 2018, Invivoscribe announced the U.S. FDA's approval for LeukoStrat CDx FLT3 Mutation Assay and XOSPATA, an AML drug manufactured by Astellas Pharma.

Growing collaborations among market players and academic and research organizations are anticipated to boost growth during the forecast period. For instance, in May 2018, Invivoscribe Technologies Inc. collaborated with the American University of Beirut Medical Center (AUBMC) in order to design and build a new center for excellence treatment in the Middle East region for advanced research in hemato oncology testing as well as treatment.

Hemato Oncology Testing Market Report Highlights

  • Lymphoma held a dominant share in terms of revenue in the cancer type segment owing to a rise in the prevalence of Hodgkin and Non-Hodgkin Lymphoma
  • The services segment captured the largest market share due to an increase in the incidence rate and rising awareness regarding various treatment therapies such as personalized medicines
  • The PCR segment dominated the market in terms of revenue share in 2019 and witnessed exponential growth owing to its ease in use, affordability, the accuracy and efficiency provided, rise in the number of product launches and approval, technological advancements of testing products, and easy availability
  • The hospitals segment witnessed exponential growth in 2019 owing to the availability of hemato oncology diagnostic tests and the presence of healthcare professionals to conduct diagnostic tests and monitor the disease
  • In North America, the market is expected to witness exponential growth during the forecast period owing to a rise in the prevalence of multiple myeloma, the growing number of awareness and screening campaigns, and the launch of technologically advanced products for the diagnosis of hemato oncology

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market segmentation & scope
  • 1.2 Market definition
  • 1.3 Information procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources & Third Party Perspectives
    • 1.3.4 Primary Research
  • 1.4 Information analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market formulation & data visualization
  • 1.6 Data validation & publishing

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
  • 2.3 Competitive Insights

Chapter 3 Hemato Oncology Testing Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent market outlook
    • 3.1.2 Ancillary market outlook
  • 3.2 Penetration and Growth Prospect Mapping
    • 3.2.1 User perspective analysis
      • 3.2.1.1 Consumer behavior analysis
  • 3.3 Regulatory Framework
    • 3.3.1 Reimbursement framework
    • 3.3.2 Standards and compliances
  • 3.4 Market Dynamics
    • 3.4.1 Market driver analysis
      • 3.4.1.1 Increasing prevalence of lymphoma & myeloma
      • 3.4.1.2 Growing demand for personalized therapy
      • 3.4.1.3 Availability of advanced molecular techniques for hemato-oncology diagnostics
      • 3.4.1.4 Increasing drug-diagnostics co-development
    • 3.4.2 Market restraint analysis
      • 3.4.2.1 Unfavorable reimbursement scenario
    • 3.4.3 Market opportunities analysis
      • 3.4.3.1 Developing countries provide untapped markets for multinational players
    • 3.4.4 Market challenges analysis
      • 3.4.4.1 Intellectual property rights protection issues
  • 3.5 Hemato Oncology Testing Market Analysis Tools
    • 3.5.1 INDUSTRY ANALYSIS - PORTER'S
      • 3.5.1.1 Supplier Power
      • 3.5.1.2 Buyer Power
      • 3.5.1.3 Substitution Threat
      • 3.5.1.4 Threat from new entrants
      • 3.5.1.5 Competitive Rivalry
    • 3.5.2 PESTEL ANALYSIS
      • 3.5.2.1 Political Landscape
      • 3.5.2.2 Environmental Landscape
      • 3.5.2.3 Social landscape
      • 3.5.2.4 Services landscape
      • 3.5.2.5 Legal Landscape
    • 3.5.3 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS
      • 3.5.3.1 Joint ventures
      • 3.5.3.2 Mergers and acquisitions
      • 3.5.3.3 Licensing and partnership
      • 3.5.3.4 Services collaborations
      • 3.5.3.5 Strategic Divestments

Chapter 4 Hemato Oncology Testing Market - Competitive Analysis

  • 4.1 Recent Developments & Impact Analysis, by Key Market Participants
  • 4.2 Company Categorization
    • 4.2.1 List of key distributors and channel partners
    • 4.2.2 Key company market share analysis, 2019
  • 4.3 Public Companies
    • 4.3.1 Company market position analysis
  • 4.4 Private Companies
    • 4.4.1 List of key emerging companies
    • 4.4.2 Regional network map
    • 4.4.3 Company market position analysis

Chapter 5 Hemato Oncology Testing Market: Cancer Type Estimates and Trend Analysis

  • 5.1 Definition & Scope
  • 5.2 Cancer Type Market Share Analysis, 2019 & 2027
  • 5.3 Segment Dashboard
  • 5.4 Global Hemato Oncology Testing Market, by Cancer Type, 2016 to 2027
  • 5.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
  • 5.6 Leukemia
    • 5.6.1 Leukemia Market, 2016 To 2027 (USD Million)
      • 5.6.1.1 Acute Myeloid Leukemia
      • 5.6.1.1.1 Acute Myeloid Leukemia Market, 2016 To 2027 (USD Million)
      • 5.6.1.2 Acute Lymphocytic Leukemia
      • 5.6.1.2.1 Acute Lymphocytic Leukemia Market, 2016 To 2027 (USD Million)
      • 5.6.1.3 Chronic Lymphocytic Leukemia
      • 5.6.1.3.1 Chronic Lymphocytic Leukemia Market, 2016 To 2027 (USD Million)
      • 5.6.1.4 Chronic Myeloid Leukemia
      • 5.6.1.4.1 Chronic Myeloid Leukemia Market, 2016 To 2027 (USD Million)
  • 5.7 Lymphoma
    • 5.7.1 Lymphoma Market, 2016 To 2027 (USD Million)
      • 5.7.1.1 Non-Hodgkin Lymphoma
      • 5.7.1.1.1 Non-Hodgkin Lymphoma Market, 2016 To 2027 (USD Million)
      • 5.7.1.2 Hodgkin Lymphoma
      • 5.7.1.2.1 Hodgkin Lymphoma Market, 2016 To 2027 (USD Million)
  • 5.8 Myeloproliferative Neoplasms
    • 5.8.1 Myeloproliferative Neoplasms Market, 2016 TO 2027 (USD Million)
      • 5.8.1.1 Polycythemia vera
      • 5.8.1.1.1 Polycythemia vera Market, 2016 to 2027 (USD Million)
      • 5.8.1.2 Essential thrombocythemia
      • 5.8.1.2.1 Essential thrombocythemia Market, 2016 to 2027 (USD Million)
      • 5.8.1.3 Myelofibrosis
      • 5.8.1.3.1 Myelofibrosis Market, 2016 to 2027 (USD Million)
  • 5.9 Other Cancers
    • 5.9.1 OTHER CANCERS MARKET, 2016 TO 2027 (USD Million)

Chapter 6 Hemato Oncology Testing Market: Product Estimates and Trend Analysis

  • 6.1 Definition & Scope
  • 6.2 Product Market Share Analysis, 2019 & 2027
  • 6.3 Segment Dashboard
  • 6.4 Global Hemato Oncology Testing Market, by Product, 2016 to 2027
  • 6.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
  • 6.6 Assay Kits and Reagents
    • 6.6.1 Assay Kits And Reagents Market, 2016 To 2027 (USD Million)
  • 6.7 Services
    • 6.7.1 Services Market, 2016 To 2027 (USD Million)

Chapter 7 Hemato Oncology Testing Market: Technology Estimates and Trend Analysis

  • 7.1 Definition & Scope
  • 7.2 Technology Market Share Analysis, 2019 & 2027
  • 7.3 Segment Dashboard
  • 7.4 Global Hemato Oncology Testing Market, by Technology, 2016 to 2027
  • 7.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
  • 7.6 PCR
    • 7.6.1 PCR MARKET, 2016 TO 2027 (USD Million)
      • 7.6.1.1 Real-time qPCR
      • 7.6.1.1.1 Real-time qPCR Market, 2016 to 2027 (USD Million)
      • 7.6.1.2 Digital PCR
      • 7.6.1.2.1 Digital PCR Market, 2016 to 2027 (USD Million)
  • 7.7 IHC
    • 7.7.1 IHC MARKET, 2016 TO 2027 (USD Million)
  • 7.8 NGS
    • 7.8.1 NGS MARKET, 2016 TO 2027 (USD Million)
  • 7.9 Cytogenetics
    • 7.9.1 CYTOGENETICS MARKET, 2016 TO 2027 (USD Million)
  • 7.10 Other Technologies
    • 7.10.1 OTHER TECHNOLOGIES MARKET, 2016 TO 2027 (USD Million)

Chapter 8 Hemato Oncology Testing Market: End Use Estimates and Trend Analysis

  • 8.1 Definition & Scope
  • 8.2 End Use Market Share Analysis, 2019 & 2027
  • 8.3 Segment Dashboard
  • 8.4 Global Hemato Oncology Testing Market, by End Use, 2016 to 2027
  • 8.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
  • 8.6 Hospitals
    • 8.6.1 Hospitals Market, 2016 TO 2027 (USD Million)
  • 8.7 Academic & Research Institutes
    • 8.7.1 Academic & Research Institutes Market, 2016 TO 2027 (USD Million)
  • 8.8 Others
    • 8.8.1 Others Market, 2016 TO 2027 (USD Million)

Chapter 9 Hemato Oncology Testing Market: Regional Estimates & Trend Analysis

  • 9.1 Regional Market Snapshot
  • 9.2 Market Share Analysis by Country, 2019
    • 9.2.1 NORTH AMERICA
      • 9.2.1.1 U.S.
      • 9.2.1.2 Canada
    • 9.2.2 EUROPE
      • 9.2.2.1 U.K.
      • 9.2.2.2 Germany
      • 9.2.2.3 Spain
      • 9.2.2.4 France
      • 9.2.2.5 Italy
      • 9.2.2.6 Russia
    • 9.2.3 LATIN AMERICA
      • 9.2.3.1 Brazil
      • 9.2.3.2 Mexico
      • 9.2.3.3 Argentina
    • 9.2.4 ASIA PACIFIC
      • 9.2.4.1 Japan
      • 9.2.4.2 China
      • 9.2.4.3 India
      • 9.2.4.4 South Korea
      • 9.2.4.5 Australia
      • 9.2.4.6 Singapore
    • 9.2.5 MIDDLE EAST & AFRICA
      • 9.2.5.1 South Africa
      • 9.2.5.2 Saudi Arabia
      • 9.2.5.3 UAE
  • 9.3 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
    • 9.3.1 NORTH AMERICA
    • 9.3.2 EUROPE
    • 9.3.3 LATIN AMERICA
    • 9.3.4 ASIA PACIFIC
    • 9.3.5 MIDDLE EAST & AFRICA
  • 9.4 Market Size & Forecasts, and Trend Analysis, 2016 to 2027
    • 9.4.1 NORTH AMERICA
      • 9.4.1.1 North America Market Size, & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
      • 9.4.1.2 U.S.
      • 9.4.1.2.1 U.S. Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
      • 9.4.1.2.2 U.S. Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
      • 9.4.1.2.3 U.S. Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
      • 9.4.1.2.4 U.S. Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
      • 9.4.1.3 Canada
      • 9.4.1.3.1 Canada Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
      • 9.4.1.3.2 Canada Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
      • 9.4.1.3.3 Canada Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
      • 9.4.1.3.4 Canada Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
    • 9.4.2 EUROPE
      • 9.4.2.1 Europe Market Size, & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
      • 9.4.2.2 U.K.
      • 9.4.2.2.1 U.K. Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
      • 9.4.2.2.2 U.K. Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
      • 9.4.2.2.3 U.K. Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
      • 9.4.2.2.4 U.K. Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
      • 9.4.2.3 Germany
      • 9.4.2.3.1 Germany Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
      • 9.4.2.3.2 Germany Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
      • 9.4.2.3.3 Germany Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
      • 9.4.2.3.4 Germany Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
      • 9.4.2.4 France
      • 9.4.2.4.1 France Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
      • 9.4.2.4.2 France Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
      • 9.4.2.4.3 France Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
      • 9.4.2.4.4 France Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
      • 9.4.2.5 Italy
      • 9.4.2.5.1 Italy Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
      • 9.4.2.5.2 Italy Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
      • 9.4.2.5.3 Italy Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
      • 9.4.2.5.4 Italy Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
      • 9.4.2.6 Spain
      • 9.4.2.6.1 Spain Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
      • 9.4.2.6.2 Spain Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
      • 9.4.2.6.3 Spain Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
      • 9.4.2.6.4 Spain Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
      • 9.4.2.7 Russia
      • 9.4.2.7.1 Russia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
      • 9.4.2.7.2 Russia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
      • 9.4.2.7.3 Russia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
      • 9.4.2.7.4 Russia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
    • 9.4.3 ASIA PACIFIC
      • 9.4.3.1 Asia Pacific Market Size, & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
      • 9.4.3.2 Japan
      • 9.4.3.2.1 Japan Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
      • 9.4.3.2.2 Japan Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
      • 9.4.3.2.3 Japan Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
      • 9.4.3.2.4 Japan Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
      • 9.4.3.3 China
      • 9.4.3.3.1 China Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
      • 9.4.3.3.2 China Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
      • 9.4.3.3.3 China Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
      • 9.4.3.3.4 China Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
      • 9.4.3.4 India
      • 9.4.3.4.1 India Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
      • 9.4.3.4.2 India Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
      • 9.4.3.4.3 India Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
      • 9.4.3.4.4 India Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
      • 9.4.3.5 South Korea
      • 9.4.3.5.1 South Korea Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
      • 9.4.3.5.2 South Korea Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
      • 9.4.3.5.3 South Korea Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
      • 9.4.3.5.4 South Korea Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
      • 9.4.3.6 Australia
      • 9.4.3.6.1 Australia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
      • 9.4.3.6.2 Australia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
      • 9.4.3.6.3 Australia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
      • 9.4.3.6.4 Australia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
      • 9.4.3.7 Singapore
      • 9.4.3.7.1 Singapore Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
      • 9.4.3.7.2 Singapore Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
      • 9.4.3.7.3 Singapore Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
      • 9.4.3.7.4 Singapore Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
    • 9.4.4 LATIN AMERICA
      • 9.4.4.1 Latin America Market Size, & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
      • 9.4.4.2 Brazil
      • 9.4.4.2.1 Brazil Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
      • 9.4.4.2.2 Brazil Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
      • 9.4.4.2.3 Brazil Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
      • 9.4.4.2.4 Brazil Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
      • 9.4.4.3 Mexico
      • 9.4.4.3.1 Mexico Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
      • 9.4.4.3.2 Mexico Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
      • 9.4.4.3.3 Mexico Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
      • 9.4.4.3.4 Mexico Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
      • 9.4.4.4 Argentina
      • 9.4.4.4.1 Argentina Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
      • 9.4.4.4.2 Argentina Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
      • 9.4.4.4.3 Argentina Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
      • 9.4.4.4.4 Argentina Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
    • 9.4.5 MIDDLE EAST & AFRICA
      • 9.4.5.1 Middle East & Africa Market Size, & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
      • 9.4.5.2 South Africa
      • 9.4.5.2.1 South Africa Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
      • 9.4.5.2.2 South Africa Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
      • 9.4.5.2.3 South Africa Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
      • 9.4.5.2.4 South Africa Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
      • 9.4.5.3 Saudi Arabia
      • 9.4.5.3.1 Saudi Arabia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
      • 9.4.5.3.2 Saudi Arabia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
      • 9.4.5.3.3 Saudi Arabia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
      • 9.4.5.3.4 Saudi Arabia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
      • 9.4.5.4 UAE
      • 9.4.5.4.1 UAE Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
      • 9.4.5.4.2 UAE Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
      • 9.4.5.4.3 UAE Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
      • 9.4.5.4.4 UAE Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)

Chapter 10 COMPANY PROFILES

  • 10.1 Company Profiles
    • 10.1.1 F. HOFFMAN-LA ROCHE LTD.
      • 10.1.1.1 Company overview
      • 10.1.1.2 Financial performance
      • 10.1.1.3 Product benchmarking
      • 10.1.1.4 Strategic initiatives
    • 10.1.2 ABBOTT LABORATORIES
      • 10.1.2.1 Company overview
      • 10.1.2.2 Financial performance
      • 10.1.2.3 Product benchmarking
      • 10.1.2.4 Strategic initiatives
    • 10.1.3 QIAGEN N.V.
      • 10.1.3.1 Company overview
      • 10.1.3.2 Financial performance
      • 10.1.3.3 Product benchmarking
      • 10.1.3.4 Strategic initiatives
    • 10.1.4 THERMO FISHER SCIENTIFIC, INC.
      • 10.1.4.1 Company overview
      • 10.1.4.2 Financial performance
      • 10.1.4.3 Product benchmarking
      • 10.1.4.4 Strategic initiatives
    • 10.1.5 ILLUMINA, INC.
      • 10.1.5.1 Company overview
      • 10.1.5.2 Financial performance
      • 10.1.5.3 Product benchmarking
      • 10.1.5.4 Strategic initiatives
    • 10.1.6 BIO-RAD LABORATORIES, INC.
      • 10.1.6.1 Company overview
      • 10.1.6.2 Financial performance
      • 10.1.6.3 Product benchmarking
      • 10.1.6.4 Strategic initiatives
    • 10.1.7 MOLECULARMD
      • 10.1.7.1 Company overview
      • 10.1.7.2 Financial performance
      • 10.1.7.3 Product benchmarking
      • 10.1.7.4 Strategic initiatives
    • 10.1.8 ARCHERDX, INC.
      • 10.1.8.1 Company overview
      • 10.1.8.2 Financial performance
      • 10.1.8.3 Product benchmarking
      • 10.1.8.4 Strategic initiatives
    • 10.1.9 ARUP LABORATORIES INC.
      • 10.1.9.1 Company overview
      • 10.1.9.2 Financial performance
      • 10.1.9.3 Product benchmarking
      • 10.1.9.4 Strategic initiatives
    • 10.1.10 ASURAGEN, INC.
      • 10.1.10.1 Company overview
      • 10.1.10.2 Financial performance
      • 10.1.10.3 Product benchmarking
      • 10.1.10.4 Strategic initiatives
    • 10.1.11 INVIVOSCRIBE, INC.
      • 10.1.11.1 Company overview
      • 10.1.11.2 Financial performance
      • 10.1.11.3 Product benchmarking
      • 10.1.11.4 Strategic initiatives
    • 10.1.12 ADAPTIVE BIOTECHNOLOGIES
      • 10.1.12.1 Company overview
      • 10.1.12.2 Financial performance
      • 10.1.12.3 Product benchmarking
      • 10.1.12.4 Strategic initiatives
    • 10.1.13 CEPHEID
      • 10.1.13.1 Company overview
      • 10.1.13.2 Financial performance
      • 10.1.13.3 Product benchmarking
      • 10.1.13.4 Strategic initiatives
    • 10.1.14 ENTROGEN, INC.
      • 10.1.14.1 Company overview
      • 10.1.14.2 Financial performance
      • 10.1.14.3 Product benchmarking
      • 10.1.14.4 Strategic initiatives
    • 10.1.15 AMOY DIAGNOSTICS CO., LTD
      • 10.1.15.1 Company overview
      • 10.1.15.2 Financial performance
      • 10.1.15.3 Product benchmarking
      • 10.1.15.4 Strategic initiatives

List of Tables

  • Table 1 List of key distributors and channel partners
  • Table 2 List of key emerging companies/product disruptors/innovators
  • Table 3 North America Hemato Oncology Testing Market, by countries, 2016 - 2027 (USD Million)
  • Table 4 North America Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
  • Table 5 North America Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
  • Table 6 North America Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
  • Table 7 North America Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
  • Table 8 U.S. Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
  • Table 9 U.S. Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
  • Table 10 U.S. Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
  • Table 11 U.S. Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
  • Table 12 Canada Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
  • Table 13 Canada Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
  • Table 14 Canada Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
  • Table 15 Canada Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
  • Table 16 Europe Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
  • Table 17 Europe Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
  • Table 18 Europe Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
  • Table 19 Europe Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
  • Table 20 U.K. Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
  • Table 21 U.K. Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
  • Table 22 U.K. Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
  • Table 23 U.K. Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
  • Table 24 Germany Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
  • Table 25 Germany Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
  • Table 26 Germany Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
  • Table 27 Germany Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
  • Table 28 France Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
  • Table 29 France Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
  • Table 30 France Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
  • Table 31 France Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
  • Table 32 Italy Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
  • Table 33 Italy Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
  • Table 34 Italy Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
  • Table 35 Italy Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
  • Table 36 Spain Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
  • Table 37 Spain Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
  • Table 38 Spain Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
  • Table 39 Spain Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
  • Table 40 Russia Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
  • Table 41 Russia Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
  • Table 42 Russia Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
  • Table 43 Russia Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
  • Table 44 Asia Pacific Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
  • Table 45 Asia Pacific Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
  • Table 46 Asia Pacific Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
  • Table 47 Asia Pacific Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
  • Table 48 Japan Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
  • Table 49 Japan Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
  • Table 50 Japan Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
  • Table 51 Japan Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
  • Table 52 China Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
  • Table 53 China Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
  • Table 54 China Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
  • Table 55 India Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
  • Table 56 India Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
  • Table 57 India Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
  • Table 58 India Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
  • Table 59 South Korea Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
  • Table 60 South Korea Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
  • Table 61 South Korea Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
  • Table 62 South Korea Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
  • Table 63 Australia Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
  • Table 64 Australia Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
  • Table 65 Australia Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
  • Table 66 Australia Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
  • Table 67 Singapore Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
  • Table 68 Singapore Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
  • Table 69 Singapore Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
  • Table 70 Singapore Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
  • Table 71 Latin America Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
  • Table 72 Latin America Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
  • Table 73 Latin America Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
  • Table 74 Latin America Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
  • Table 75 Brazil Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
  • Table 76 Brazil Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
  • Table 77 Brazil Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
  • Table 78 Brazil Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
  • Table 79 Mexico Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
  • Table 80 Mexico Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
  • Table 81 Mexico Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
  • Table 82 Mexico Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
  • Table 83 Argentina Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
  • Table 84 Argentina Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
  • Table 85 Argentina Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
  • Table 86 Argentina Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
  • Table 87 MEA Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
  • Table 88 MEA Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
  • Table 89 MEA Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
  • Table 90 MEA Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
  • Table 91 South Africa Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
  • Table 92 South Africa Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
  • Table 93 South Africa Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
  • Table 94 South Africa Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
  • Table 95 Saudi Arabia Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
  • Table 96 Saudi Arabia Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
  • Table 97 Saudi Arabia Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
  • Table 98 Saudi Arabia Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
  • Table 99 UAE Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
  • Table 100 UAE Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
  • Table 101 UAE Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
  • Table 102 UAE Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)

List of Figures

  • Fig. 1 Hemato Oncology Testing Market Segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain based sizing & forecasting
  • Fig. 7 Hemato Oncology Testing Market Snapshot (2019)
  • Fig. 8 Hemato Oncology Testing Market: Segment Snapshot (2019)
  • Fig. 9 Competitive Insights (2019)
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Hemato Oncology Testing Market: Driver Impact
  • Fig. 15 Hemato Oncology Testing Market: Restraint Impact
  • Fig. 16 Hemato Oncology Testing Market: Opportunities Impact
  • Fig. 17 Hemato Oncology Testing Market: Challenges Impact
  • Fig. 18 Porter's Five Forces Analysis
  • Fig. 19 SWOT Analysis, By Factor (Political & Legal, Economic and technological)
  • Fig. 20 Strategic alliance analysis
  • Fig. 21 Recent developments & impact analysis, by key market participants
  • Fig. 22 Key company market share analysis, 2019
  • Fig. 23 Company market share/ranking, by region
  • Fig. 24 Company market position analysis
  • Fig. 25 Cancer type market share analysis, 2019 & 2027
  • Fig. 26 Segment dashboard
  • Fig. 27 Global Hemato Oncology Testing Market, by Cancer Type, 2016 - 2027 (USD Million)
  • Fig. 28 Global Leukemia Market, 2016 - 2027 (USD Million)
  • Fig. 29 Global Acute Myeloid Leukemia Market, 2016 - 2027 (USD Million)
  • Fig. 30 Global Acute Lymphocytic Leukemia Market, 2016 - 2027 (USD Million)
  • Fig. 31 Global Chronic Lymphocytic Leukemia Market, 2016 - 2027 (USD Million)
  • Fig. 32 Global Chronic Myeloid Leukemia Market, 2016 - 2027 (USD Million)
  • Fig. 33 Global Lymphoma Market, 2016 - 2027 (USD Million)
  • Fig. 34 Global Non-Hodgkin Lymphoma Market, 2016 - 2027 (USD Million)
  • Fig. 35 Global Hodgkin Lymphoma Market, 2016 - 2027 (USD Million)
  • Fig. 36 Global Myeloproliferative Neoplasms Market, 2016 - 2027 (USD Million)
  • Fig. 37 Global Polycythemia vera Market, 2016 - 2027 (USD Million)
  • Fig. 38 Global Essential thrombocythemia Market, 2016 - 2027 (USD Million)
  • Fig. 39 Global Myelofibrosis Market, 2016 - 2027 (USD Million)
  • Fig. 40 Global Others Cancers Market, 2016 - 2027 (USD Million)
  • Fig. 41 Global Hemato Oncology Testing Market, by Product, 2016 - 2027 (USD Million)
  • Fig. 42 Global Assay Kits and Reagents Market, 2016 - 2027 (USD Million)
  • Fig. 43 Global Services Market, 2016 - 2027 (USD Million)
  • Fig. 44 Global Hemato Oncology Testing Market, by Technology, 2016 - 2027 (USD Million)
  • Fig. 45 Global PCR Market, 2016 - 2027 (USD Million)
  • Fig. 46 Global Real-time qPCR Market, 2016 - 2027 (USD Million)
  • Fig. 47 Global Digital PCR Market, 2016 - 2027 (USD Million)
  • Fig. 48 Global IHC Market, 2016 - 2027 (USD Million)
  • Fig. 49 Global NGS Market, 2016 - 2027 (USD Million)
  • Fig. 50 Global Cytogenetics Market, 2016 - 2027 (USD Million)
  • Fig. 51 Global Others Technologies Market, 2016 - 2027 (USD Million)
  • Fig. 52 Global Hemato Oncology Testing Market, by End-Use, 2016 - 2027 (USD Million)
  • Fig. 53 Global Hospitals Market, 2016 - 2027 (USD Million)
  • Fig. 54 Global Academic & Research Institutes Market, 2016 - 2027 (USD Million)
  • Fig. 55 Global Others Market, 2016 - 2027 (USD Million)
  • Fig. 56 Hemato Oncology Testing Market Snapshot
  • Fig. 57 North America Hemato Oncology Testing Market Share Analysis by country, 2019
  • Fig. 58 Europe Hemato Oncology Testing Market Share Analysis by country, 2019
  • Fig. 59 Asia Pacific Hemato Oncology Testing Market Share Analysis by country, 2019
  • Fig. 60 Latin America Hemato Oncology Testing Market Share Analysis by country, 2019
  • Fig. 61 Middle East and Africa Hemato Oncology Testing Market Share Analysis by country, 2019
  • Fig. 62 North America SWOT Analysis, by factor (political & legal, economic and technological)
  • Fig. 63 Europe SWOT Analysis, by factor (political & legal, economic and technological)
  • Fig. 64 Asia Pacific SWOT Analysis, by factor (political & legal, economic and technological)
  • Fig. 65 Latin America SWOT Analysis, by factor (political & legal, economic and technological)
  • Fig. 66 Middle East and Africa SWOT Analysis, by factor (political & legal, economic and technological)